Please use this identifier to cite or link to this item:
Title: Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Authors: Hidalgo, M
Álvarez, R
Gallego, J
Guillén-Ponce, C
Laquente, B
Macarulla, T
Muñoz, A
Salgado, M
Vera, R
Adeva, J
Alés, I
Arévalo, S
Blázquez, J
Calsina, A
Carmona, A
de Madaria, E
Díaz, R
Díez, L
Fernández, T
de Paredes, B G
Gallardo, M E
González, I
Hernando, O
Jiménez, P
López, A
López, C
López-Ríos, F
Martín, E
Martínez, J
Martínez, A
Montans, J
Pazo, R
Plaza, J C
Peiró, I
Reina, J J
Sanjuanbenito, A
Yaya, R
Carrato, Alfredo
Keywords: Consensus guidelines;Diagnosis;Pancreatic cancer;Treatment
metadata.dc.subject.mesh: Carcinoma, Pancreatic Ductal
Follow-Up Studies
Pancreatic Neoplasms
Practice Guidelines as Topic
Issue Date: 19-Dec-2016
Abstract: The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
metadata.dc.identifier.doi: 10.1007/s12094-016-1594-x
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5427095.pdf586,32 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons